Latest News

Bio-Safety Laboratory Deploys Provantis Software Solution to Help Streamline Non-Clinical Evaluation Studies

Provantis Selected to Automate Processes in the Research of Deadly Pathogens, Emerging Diseases and Bioterror Agents

CONSHOHOCKEN, PA - June 21, 2016 - Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that Texas Biomedical Research Institute (Texas Biomed), based in San Antonio, Texas, has purchased the Provantis┬« preclinical solution suite to support bio-safety level 4 (BSL-4) research and documentation processes.


Instem Exhibiting at Leading Industry Conferences in China and Japan

June 21, 2016 - Instem to Showcase Solutions for Preclinical Study Management, SEND and Genetic Toxicology


Biopharmaceutical Organization Selects Provantis® Pathology to Optimize Histopathology Reviews

June 9, 2016 - Massachusetts Based Biopharmaceutical Company Automates Histopathology Processes


BoZo Research Center Selects Instem as SEND Outsourcing Partner for Japanese Market

June 2, 2016 - BoZo Research Responds to Strong Market Demand and Becomes SEND-Enabled


Instem Acquires RIM Solution Provider Samarind

May 31, 2016 - Samarind Strengthening Global Position as Part of Instem Organization


View all news

Upcoming Events

Society of Toxicologic Pathology 35th Annual Symposium

June 26 - 30, 2016

San Diego, CA

Booth 200

Visit Conference Site


The 6th National Congress of Toxicology of CSOT

June 28 - July 1, 2016

Chongqing City, China

Booth C3

Visit Conference Site


43rd Annual Meeting of the Japanese Society of Toxicology

June 29 - July 1, 2016

Nagoya, Japan

Booth 84

Visit Conference Site

View all events